TrialThe Journal of pediatrics2015
Safety of Early High-Dose Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants.
Jean-Claude Fauchère et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this paperpooled ittrialcites it